Pharmacotherapy Based on ACE2 Targeting and COVID-19 Infection

The new SARS-CoV-2 coronavirus is responsible for the COVID-19 pandemic. A massive vaccination campaign, which is still ongoing, has averted most serious consequences worldwide; however, lines of research are continuing to identify the best drug therapies to treat COVID-19 infection. SARS-CoV-2 pene...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitiello, Antonio, Ferrara, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224264/
https://www.ncbi.nlm.nih.gov/pubmed/35743089
http://dx.doi.org/10.3390/ijms23126644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224264/
https://www.ncbi.nlm.nih.gov/pubmed/35743089
http://dx.doi.org/10.3390/ijms23126644

Ejemplares similares